Profund Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $383K | Sell |
10,622
-992
| -9% | -$35.7K | 0.01% | 564 |
|
|
2025
Q1 | $362K | Sell |
11,614
-4,128
| -26% | -$129K | 0.02% | 590 |
|
|
2024
Q4 | $402K | Sell |
15,742
-663
| -4% | -$16.9K | 0.01% | 626 |
|
|
2024
Q3 | $464K | Sell |
16,405
-404
| -2% | -$11.4K | 0.02% | 561 |
|
|
2024
Q2 | $443K | Sell |
16,809
-3,238
| -16% | -$85.4K | 0.02% | 541 |
|
|
2024
Q1 | $609K | Buy |
20,047
+1,753
| +10% | +$53.2K | 0.02% | 512 |
|
|
2023
Q4 | $514K | Sell |
18,294
-2,123
| -10% | -$59.6K | 0.02% | 508 |
|
|
2023
Q3 | $554K | Buy |
20,417
+2,071
| +11% | +$56.2K | 0.03% | 439 |
|
|
2023
Q2 | $564K | Buy |
18,346
+876
| +5% | +$26.9K | 0.03% | 473 |
|
|
2023
Q1 | $629K | Sell |
17,470
-3,670
| -17% | -$132K | 0.04% | 433 |
|
|
2022
Q4 | $835K | Buy |
21,140
+817
| +4% | +$32.3K | 0.05% | 299 |
|
|
2022
Q3 | $817K | Sell |
20,323
-3,264
| -14% | -$131K | 0.06% | 279 |
|
|
2022
Q2 | $992K | Sell |
23,587
-1,043
| -4% | -$43.9K | 0.06% | 262 |
|
|
2022
Q1 | $960K | Sell |
24,630
-1,869
| -7% | -$72.8K | 0.04% | 323 |
|
|
2021
Q4 | $1.06M | Buy |
26,499
+426
| +2% | +$17K | 0.03% | 319 |
|
|
2021
Q3 | $942K | Buy |
26,073
+18,634
| +250% | +$673K | 0.03% | 379 |
|
|
2021
Q2 | $305K | Buy |
7,439
+754
| +11% | +$30.9K | 0.01% | 1050 |
|
|
2021
Q1 | $292K | Sell |
6,685
-384
| -5% | -$16.8K | 0.01% | 1001 |
|
|
2020
Q4 | $354K | Buy |
7,069
+500
| +8% | +$25K | 0.02% | 727 |
|
|
2020
Q3 | $276K | Buy |
+6,569
| New | +$276K | 0.01% | 712 |
|